IDT Acquires Singapore Firm's Oligonucleotide Business | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Integrated DNA Technologies has acquired the oligonucleotide business of Singapore's 1st Base for an undisclosed amount, IDT announced today.

The new company has been renamed 1st Base Custom Oligos (FBCO) and will offer locally manufactured oligos throughout Singapore and the region. The company is IDT's first synthesis facility in Asia, it said, adding that it will keep the 1st Base brand for small-scale DNA oligos synthesized in Singapore.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.